⌘K

Login Start Free

Home/Filings/4/0001385508-23-000018

4//SEC Filing

CRYSTAL ROGER 4

Accession 0001385508-23-000018

CIK 0001385508other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 5:09 PM ET

Size

4.8 KB

Accession

0001385508-23-000018

Insider Transaction Report

Form 4

Period: 2023-01-09

OPIANT PHARMACEUTICALS, INC.OPNT

DirectorChief Executive Officer10% Owner

Transactions

Sale
Common Stock
2023-01-09$20.20/sh−1,183$23,897→ 76,697 total

Footnotes (1)

[F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Documents

1 file

4
wf-form4_167330214981696.xmlPrimary
FORM 4

Issuer

OPIANT PHARMACEUTICALS, INC.

CIK 0001385508

Entity typeother

Related Parties

1

filerCIK 0001656633

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 5:09 PM ET
Size: 4.8 KB

View on SEC.gov